EU-JAMRAI 2

The four-year (2024-2027) European Union project aims at supporting the 30 EU Member States and associated countries in their efforts to develop and update their National Action Plan (NAP) on AMR. The priorities of JAMRAI are to strengthen Member States and associated countries coordination, strengthening the responsiveness of health systems, ensuring access to critical antibiotics and diagnostic devices, and protecting citizens exposure to antimicrobial-resistant bacteria.

EU-JAMRAI 2 seeks to implement concrete actions to monitor, prevent and effectively tackle antimicrobial resistance across human, animal and environmental health domains that is through a “One-Health” approach. The project focuses on multiple areas, such as antibiotic stewardship (AMS), surveillance, awareness raising, capacity building, infection prevention and control (IPC) and behavioral science.

Statens Serum Institut takes directly part in several of the work packages:

• WP5: One Health strategies and NAP: Member State engagement
• WP7: Improve the Infection Prevention and Control (IPC) actions with a One Health approach
• WP8: Integrated One Health surveillance
• WP9: Access

Danish partners also participating in the EU-JAMRAI 2 project are: Danish Health Authority, University of Copenhagen and Technical University of Denmark.

EU-JAMRAI 2 is based on the learnings from the first Joint action on AMR and Healthcare Associated Infections (EU-JAMRAI 1) which aimed at strengthening and consolidating the work in the Member States and associated countries to contain antibiotic resistance and reduce health care associated infections.

EU-JAMRAI 2 is funded by the member states and by the EU4Health Program of EU.

The EU-JAMRAI 2 project was launched in Paris the 13th of February 2024: Additional information on the EU -JAMRAI website.